Root Financial Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Buy
7,203
+729
+11% +$157K 0.07% 82
2026
Q1
$1.41M Buy
6,474
+380
+6% +$84.3K 0.07% 81
2025
Q4
$1.39M Buy
6,094
+1,380
+29% +$314K 0.07% 73
2025
Q3
$1.09M Buy
4,714
+1,019
+28% +$208K 0.07% 81
2025
Q2
$686K Buy
3,695
+1,196
+48% +$222K 0.07% 95
2025
Q1
$524K Sell
2,499
-51
-2% -$9.91K 0.06% 111
2024
Q4
$453K Buy
2,550
+754
+42% +$139K 0.06% 121
2024
Q3
$355K Buy
1,796
+525
+41% +$98K 0.06% 112
2024
Q2
$218K Buy
+1,271
New +$211K 0.05% 106

Other funds holding ABBV

Root Financial Partners's ABBV Position: Q2 2026 in Review

Root Financial Partners increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $157K and bringing the position to 7,203 shares worth $1.81M. The position accounts for 0.07% of the portfolio, ranked #82.

Root Financial Partners first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Root Financial Partners held 7,203 shares of AbbVie worth $1.81M as of Q2 2026.
  • Root Financial Partners bought 729 AbbVie shares in Q2 2026, an estimated $157K.
  • AbbVie made up 0.07% of Root Financial Partners's portfolio in Q2 2026, its #82 holding.
  • Root Financial Partners first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.